Regulation on the prescription of medicinal products (prescription drug prescription-AMVV)

Unofficial table of contents

AMVV

Date of completion: 21.12.2005

Full quote:

" Prescription medicine regulation of 21 December 2005 (BGBl. 3632), as last amended by Article 2 of the Regulation of 6 March 2015 (BGBl I). 278).

Status:

Last amended by Art. 2 V v. 6.3.2015 I 278

For more details, please refer to the menu under Notes

Footnote

(+ + + Text evidence from: 1.1.2006 + + +) 

  

The V was defined as Article 1 of the V v. 21.12.2005 I 3632 by the Federal Ministries of Health, Food, Agriculture and Consumer Protection in agreement with the Federal Ministries of Economy and Technology, for Environment, Nature Conservation and Reactor safety and health, after consultation of the expert committee on prescription, with the consent of the Bundesrat. She's gem. Article 3 (1), first sentence, of this V entered into force on 1 January 2006. Unofficial table of contents

§ 1

Medicinal products,

1.

the substances or preparations of substances or preparations referred to in Appendix 1 to this Regulation are or are:

2.

the preparations from the substances or preparations in Appendix 1 are or are made of substances, or

3.

the substances and preparations referred to in paragraph 1 or 2 have been added to or

4.

which fall within the scope of section 48 (1), first sentence, No. 2 of the German Medicines Act,

may only be given in the presence of a medical, dental or veterinary prescription (medicinal product subject to medical prescription) unless otherwise specified in the following provisions. Unofficial table of contents

§ 2

(1) The prescription shall contain:

1.

the name, first name, professional title and address of the practice or clinic of the prescribing medical, veterinary or dental person (prescribing person), including a telephone number to contact him;

2.

the date of manufacture,

3.

the name and date of birth of the person for which the medicinal product is intended;

4.

the name of the ready-to-use product or the active substance, including the starch,

4a.

in the case of a medicinal product intended to be produced in the pharmacy, the composition according to the nature and quantity or the name of the ready-to-use medicinal product, from which subsets are to be made,

5.

the pharmaceutical form, provided that the name referred to in point 4 or point 4a is not unambiguous;

6.

the amount of the prescribed medicinal product to be dispensed,

7.

Instructions for use in medicinal products intended to be manufactured in the pharmacy,

8.

the period of validity of the prescription;

9.

in the case of veterinary prescriptions

a)

the dose per animal and day,

b)

the duration of the application; and

c)

provided that the medicinal product is prescribed for use in animals used for the production of foodstuffs, the indication and the waiting time,

and, instead of the information referred to in point 3, the name of the keeper and the number and type of animals for which the medicinal product is to be used, and in the case of prescriptions for animals used for the production of foodstuffs, the identity of the animals,

10.

the personal signature of the prescribing person or, in the case of prescriptions in electronic form, their qualified electronic signature in accordance with the signature law.

(1a) The prescriptions of medical or dental prescriptions originating in Germany shall be those of the Member States of the European Union, of the States Parties to the Agreement on the European Economic Area and of the Treaty establishing the European Economic Area. Switzerland shall, provided that they have the information referred to in paragraph 1 and thereby demonstrate their authenticity and their exhibition by a qualified medical or dental person. The provisions of § 3a as well as of the Narcotics prescriptions ordinance remain unaffected. (1b) A medical or dental prescription issued for the purpose in another Member State of the European Union, in a The Contracting State of the Agreement on the European Economic Area or in Switzerland shall contain the following information:

1.

the name, first name and date of birth of the person for which the medicinal product is intended;

2.

the date of manufacture,

3.

Name, first name and professional qualification of the prescribable medical or dental person (prescribing person),

4.

the address of the person who is prescribing, including the name of the Member State, telephone number or fax number, indicating the country code and the e-mail address of the person concerned,

5.

handwritten or digital signature of the prescribing person, depending on the medium of the prescribing,

6.

the Community code relating to medicinal products for human use referred to in Article 1 (21) of Directive 2001 /83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ L 311, 28.11.2001, 67), as last amended by Regulation (EC) No 1901/2006 (OJ L 311, 28.11.2006, p. 1), the common name of the medicinal product (international non-proprietary name); the name of a medicinal product for ready-to-use medicinal products may be used if:

a)

the medicinal product prescribed a biological medicinal product in accordance with point 3.2.1.1. Point (b) of Annex I, Part 1 of Directive 2001 /83/EC, or

b)

the prescribing person considers it necessary for medical purposes; in this case, the prescription shall contain a short justification for the use of the product name for the ready-to-use medicinal product,

7.

the amount of the prescribed medicinal product to be dispensed, its potency within the meaning of Directive 2001 /83/EC and the form of administration,

8.

Dosage.

(2) Is the prescription for the practical needs of a prescribing person, for a hospital, for facilities or subunits of facilities of the rescue service, for on-board pharmacy of aircraft according to § 1 para. 2 no. 1 and 2 of the Operating Regulations for Aeronautical Equipment of 4 March 1970 (BGBl. 262), as last amended by Article 449 of the Regulation of 29 June 1994. October 2001 (BGBl. 2785), the information referred to in paragraph 1 (3), (7) and (9) shall be replaced by an appropriate endorsement. (3) The prescription of a medicinal product to be used for the preparation of a veterinary medicinal product. Abortion is permitted only in a facility within the meaning of § 13 of the Maternity Conflict Act of 27 July 1992 (BGBl. I p. 1398), as defined by Article 1 of the Law of 21 August 1995 (BGBl. 1050), the information referred to in paragraph 1 (3) shall be replaced by an appropriate endorsement. (4) In the case of medicinal products in the ready-to-release package, the indication of the amount of the prescribed medicinal product shall be given. the smallest package shall be deemed to be prescribed. (5) If the period of validity is not specified, the prescription shall be valid for three months. (6) If the date of birth of the person for which the medicinal product is intended is missing, or where the information referred to in paragraph 1 (2), (5) or (7) is missing, or if it is incomplete, the pharmacist may, if there is an urgent case, and (7) If the prescription of a medicinal product is intended for a hospital in which there is a system for the transmission of the same, a hospital is provided, in the case of prescribing by a person who is responsible for the prescribing, the name reproduction of the person who is prescribing or, in the case of prescriptions in electronic form, shall be sufficient in place of the personal signature referred to in paragraph 1 (10). appropriate electronic identification method. (8) Is the prescription for a hospital, it can also be transmitted exclusively with the aid of a telefax machine. Unofficial table of contents

§ 3

The prescription of a medicinal product within the meaning of section 2 (3) shall be drawn up in two copies (original and transcript). The original and the copy shall be transmitted to the pharmaceutical company. The copy must be accompanied by the serial number of the packages delivered in accordance with § 47a (2) sentence 1 of the German Medicines Act and the date of the submission and the copy with the medicinal product of the institution in accordance with § § 47a (2) sentence 1 of the German Medicines Act. 13 of the Pregnancy Conflict Act. The originals remain with the pharmaceutical company. The latter shall keep the originals for a period of five years and shall submit them upon request to the competent authority. On the copy of the prescription, the prescribing person shall record the date of receipt and application of the medicinal product as well as the assignment to the concrete patient records in an anonymized form. It shall keep the copies for a period of five years and shall submit it to the competent authority at the request of the competent authority for inspection. For prescriptions in electronic form, the sentences 1 to 7 shall apply accordingly. Unofficial table of contents

§ 3a

(1) A prescription of medicinal products containing the active substances lenalidomide, pomalidomide or thalidomide may only be prescribed on a numbered two-part official form (original and transcript) of the Federal Institute for Medicinal Products and Medical devices are performed. The forms referred to in the first sentence shall be determined solely for the prescription of the medicinal products referred to in the first sentence. (2) prescriptions referred to in the first sentence of paragraph 1 shall include the confirmation of the medical person that the security measures shall be taken in accordance with the provisions of the the current information on the relevant finished product, in particular that a pregnancy prevention programme is carried out if necessary and that the patient or the patient before the start of the medicinal product is Treatment appropriate medical information materials and the current Package leaflet of the corresponding ready-to-use medicinal product have been handed out. In addition, the prescription shall indicate whether a treatment is carried out inside or outside the designated areas of application. (3) The maximum amount of medicinal products prescribed for prescriptions referred to in the first sentence of paragraph 1 may be: (4) By way of derogation from § 2 (5), a prescription as referred to in the first sentence of paragraph 1 is up to six days after the date of their exhibition. valid. (5) Forms referred to in the first sentence of paragraph 1 shall be published by the Federal Institute for Drugs and Medical Devices Request to the individual medical person against proof of medical examination of the medicine. The requirement shall be accompanied by a statement by the medical person that:

1.

you have received the medical information materials for lenalidomide, pomalidomide or thalidomide according to the current specialist information of corresponding ready-made medicinal products,

2.

the prescription of medicinal products referred to in the first sentence of paragraph 1 will comply with all safety measures in accordance with the current technical information of appropriate pre-prepared medicinal products; and

3.

it has sufficient expertise to prescribe medicinal products as referred to in the first sentence of paragraph 1.

(6) The Federal Institute for Medicinal Products and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte-Bundesinstitut für Arzneimittel und Medizinprodukte-Bundesinstitut für Arzneimittel und Medizinprodukte-Bundesinstitut für Arzneimittel und Medizinprodukte-Bundesinstitut für Arzneimittel und Medizinprodukte-Bundesinstitut für Arzneimittel und Medizinprodukte ") is making a Forms referred to in the first sentence of paragraph 1. Unofficial table of contents

§ 4

(1) In the case of a medicinal product subject to medical prescription, the prescribing person shall be able to inform the pharmacist in an appropriate manner, in particular by telephone, about the prescription and the content thereof. The pharmacist has to give certainty about the identity of the prescribing person. The prescribing person shall immediately give the pharmacist the prescription in written or electronic form. (2) For the self-requirement of a prescribing person, the prescribing shall not require the written or electronic prescription. Shape. The second sentence of paragraph 1 shall apply accordingly. (3) The repeated delivery of a medicinal product subject to medical prescription to the same prescription beyond the prescribed quantity shall be inadmissible. Unofficial table of contents

§ 5

The prescription shall not apply to medicinal products derived from the substances and preparations of substances referred to in Appendix 1 to this Regulation, in accordance with a homeopathic procedure, in particular in accordance with the rules of homeopathic Medicinal products are produced or consist of mixtures of such substances or preparations of substances, if the final concentration of these medicinal products in the finished product does not exceed the fourth decimal potency. These medicinal products may also be mixed with substances and preparations not subject to medical prescription. Unofficial table of contents

§ 6

The obligation to presenter pursuant to section 48 (1), first sentence, of the Medicines Act shall not apply to medicinal products which are neither a substance listed in Appendix 2, its preparation or salt, nor any such substance, such preparation, or containing such a salt. Unofficial table of contents

§ 7

(dropped) Unofficial table of contents

§ 8 (omitted)

- Unofficial table of contents

§ 9

By way of derogation from § 1 in conjunction with Appendix 1, in so far as the substance Na-Nifur-styrenate or the substance Sarafloxacin is concerned, a veterinary medicinal product which is exclusively for use in the animal species referred to in § 60 (1) of the Medicines Act shall be placed on the market before 1 January 2010 and shall be delivered without prescription until 1 January 2012. Unofficial table of contents

Appendix 1 (to § 1 No. 1 and § 5)
Substances and preparations according to § 1 no. 1

The plant contains an alphabetically ordered list of substances and preparations, with the basic use of the INN nomenclature.
Unless otherwise specified in individual cases, medicinal products containing the respective salts of the substances listed below or to which they are added shall also be subject to medical prescription.
For the purposes of this overview, use is to be used on the skin, hair or nails. Abacavir
Abamectin
Abarelix
Abatacept
Abirateron and its esters
Acamprosy
Acarbose
Acebutolol
Acecarbromal
Aceclidine
Aceclofenac
Acemetacin
Acenocoumarol
Acetanilide
Acetazolamide
Acetylcholine
-for parenteral administration-
Acetylcysteine
-except for oral use in acute colds in humans-
N-acetylgalactosamine-4-sulfatase from human beings, recombinant, modified (galsulfase)
Acetylsalicylic acid
-for parenteral administration-
Aciclovir
-except in preparations as a cream for use in herpes labialis in pack sizes of up to 2 g and with an active substance content of up to 100 mg per dose of medicinal product.
Acipimox
Acitretin
Aclarubicin
Aclidinium salts
Aconitum: species of the genus Aconitum, its parts and preparations thereof as well as aconitum alkaloids and their derivatives
-except for external use in ointments,
-except in homeopathic preparations for oral use produced in accordance with the rules 25 and 26 of the homeopathic medicinal book,
Adapals
Adefovir
Ademetionin
Adenosine
Afatinib
Aflibercept
Agalsidase alfa and beta
Agaricinic acid
Aglepriston
-for use in animals,
Agomelatine
Ajmalin and its esters
N2-L-Alanyl-L-glutamine
-for parenteral administration-
Alatrofloxacin
Albendazole
Alclofenac
Alclometason and its esters
Aldesleukin
Aldosterone and its Halbacetal
Alendronic acid
Alfacalcidol
Alfadolon and its esters
Alfaxalon
Alfuzosin
Alglucosidase alfa
Alipogen Tiparvovec
Aliskiren
Alitretinoin
Alizaprid
Alkuronium salts
N-alkylatropinium salts
Allopurinol
Allylestrenol
Almotriptan
-except for the acute treatment of the headache in migraine attacks with and without aura in adults between 18 and 65 years of age, after initial diagnosis of migraine by a doctor, in solid preparations for oral use in concentrations of 12.5 mg of each form and in a total quantity of 25 mg per pack,
Alogliptin
Alprenolol
Alprostadil
Alteplase
Altrenogest
-for use in animals,
Altretamine
Amantadine
Ambenonium salts
Ambrisentan
Ambroxol
-for parenteral administration-
Ambutonium bromide
Amcinonide
Ameziniummetilsulphate
Amifampridine
Amifostin
Amikacin
Amilomer
Amilorid
4-Aminobenzoic acid
-where a daily dose of up to 1.5 g is not indicated on containers and outer envelopes,
Aminocaproic acid
Aminoglutethimide
4-Amino-2-hydroxybenzoic acid and its derivatives
4-(Aminomethyl) benzoic acid
-for oral and parenteral administration,
5-amino-4-oxopentanoic acid
Aminopterin
Amiodarone
Amiphenazole
Amisulprid
Amitraz
-for use in pigs,
Amitriptyline
Amitriptyline oxide
Amlexanox
Amlodipine
Amodiaquin
Amoxicillin
Amperozid
-for use in animals,
Amphotericin B
Ampicillin
Amprenavir
Amrinon
Amsacrin
Amygdalarum amararum aethereum, oleum (diaceous)
Amylenhydrate
Isopentyl nitrite
Anageston
Anagrelide
Anakinra
Anastrozole
Ancrod
Androstanolon and its esters
Androstenone
-for use in animals,
Anetholtrithion
Angiotensinamide
Anidulafungin
Anistreplase
Antimony compounds
-excluding antimony (III)-sulphide and antimony (V)-sulphide-
Antithrombin III
Aortic valve of the pig, denatured
Apalcillin
Apiol
Apixaban
Apomorphine
Apraclonidine
Apramycin
-for use in animals,
Aprepitant
Aprindin
Apronalid
Aprotinin
Ardeparin
-for parenteral administration-
Arecolin
Argatroban
Argininoxoglurat
Aripiprazole
Arsenic and its compounds
Species imol and its esters and ethers
Artemether
Articain
Ascaridol
Asenapine
L-Asparaginase
Aspidinolfilizin
Astemizole
Atazanavir
Atenolol
Atipamezole
-for use in animals,
Atomoxetine
Atorvastatin
Atosiban
Atovaquon
Atracurium salts
Atropine
Auranofine
Aurothioglucose
Avanafil
Axitinib
Azacitidine
Azacosterol
Azamethonium salts
Azaperone
Azapropazon
Azatadin
Azathioprine
Azelaic acid
Azelastine
-with the exception of intranasal use for the treatment of seasonal allergic rhinitis in adults and children from the age of 6. Year of Life-
-except for use in the eye,
Azidamfenicol, its esters and compounds
Azidocillin
Azilsartan and its esters
Azithromycin
Azlocillin
Azosemide
AztreonamBacampicillin
Bacillus Calmette-Guérin
-for immunostimulation,
Bacitracin
-with the exception of preparations for local use in people on the skin or mucous membrane, provided that they are not more than 500 IU per gram or in the case of other preparations per gram or millilitre, per gram or millilitre of preparations for each part of the product. (9,1 mg) Bacitracin contains-
Baclofen
Bambuterol
Bamifylline
Bazedoxifen and its esters
Becaplermin
Beclamid
Beclometason and its esters
-except beclomethasone dipropionate for intranasal use in the short-term treatment of seasonal allergic rhinitis in pack sizes up to 5.5 mg of beclometasondipropionate, provided that the containers and the outer envelopes indicate that the Application to adults and children from the age of 12. Year of life is limited to
Befunolol
Belatacept
Belladonnae folium and its preparations
-except for external use,
-except in homeopathic preparations for oral use produced in accordance with the rules 25 and 26 of the homeopathic medicinal book,
Bemegrid
Bemetizid
Bemiparin
-for parenteral administration-
Benactyzine
Benazepril
Bencyclan
Bendamustin
Bendroflumethiazid
Benfurodil and its esters
Benmoxin
Benperidol
Benserazide
Bentiromid
Benzaldehyde cyanohydrin
Benzaldehyde thiosemicarbazone and its derivatives
Benzatropine
Benzbromaron
Benzetimid
-for use in animals,
Benzilonium bromide
Benzocaine
-with the exception of medicinal products for application to the skin or mucosa, except for use in the eye,
Benzoctamine
Benzthiazide
Benzydamine
-except for use in the mouth and throat area

a)

as a solution with a benzydamine hydrochloride concentration of no more than 1.5 mg/ml; or

b)

as a lutschtablette with a maximum of 3 mg of benzydamine hydrochloride per divided form-

Benzylhydrochlorothiazide
Benzylpenicillin and its esters
Narcotics, insofar as they are preparations in accordance with § 2 (1) (3) of the Narcotics Act
Betahist
Betaine
Betamethasone and its esters
Betanidin
Betaxolol
Betiatid
-as a carrier substance for ((high) 99m Tc) technetium
Bevonium salts
Bexarotene
Bezafibrat
Bicalutamide
Bicisat
-as a kit for the production of a radiodiagnostic device with ((high) 99m Tc) technetium
Bilastin and its esters
Bimatoprost
Biperiden
2,5-Bis (aziridin-1-yl) -3,6-b is (2-methoxyethoxy) -1,4-benzoquinone
Bismuth and his connections
-for oral use-
-for intramammary use in beef and veal
-except in daily doses up to 1.5 g of bismuth and in pack sizes of up to 50 g of bismuth; this exception does not apply to bismuth (III)-citrate-hydroxide-complex-
Bisoprolol
Bithionoloxide
Bitoscanat
Bitteralmandelwasser
Bivalirudin
Lead acetate
-with the exception of lead vinegar
Lead (II) iodide
Bleomycin
Blood coagulation factors and clotting inhibitors, in each case recombinant
Blood preparations of human origin
-for medicinal use on or in the human or animal body,
Boceprevir
Boldenon and its esters
Bopindolol
Bornaprin
Bortezomib
Bosentan
Bosutinib
Bretylium salts
Brimonidine
Brinzolamide
Brivudine
Bromelain Proteases Concentrate
Bromethane
Bromfenac and its esters
Bromisoval
Bromociclen
Bromocriptine
Bromofenofos and its esters
Bromoform
Bromopride
Bromperidol
Brotianide
-for use in animals,
Brucin
Buclizin
Budesonide
Budipine
Bufeniod
Buflomedil
Bumadizon
Bumetanid
Bunamidine
-for use in animals,
Bunazosin
Bunitrolol
Bupivacain
Bupranolol
Bupropion
Buserelin
Buspiron
Busulfan
Butalamine
Butamirat
Butenafin
Butizid
Butorphanol and its esters
Butyl chloralhydrate
Butylscopolamine
-for parenteral use--C1 inhibitor of human
Cabazitaxel and its esters
Cabergolin
Cactinomycin
Calabar semen and its preparations
Calcifediol
Calcipotriol
Calcitonin as well as calcitonin-containing organ preparations
Calcitriol
Calcium dobesilate
Cambendazole
-for use in animals,
Canagliflozin and its derivatives
Candesartan and its esters
Canrenoinic acid and its esters
Cantharides and their preparations
-except for external use in plasters, ointments or similar preparations,
Cantharidin
Capecitabine
Capreomycin
Capsaicin and its esters
-for the treatment of peripheral neuropathic pain-
Captodiam
Captopril
Caramiphen
Carazolol
Carbachol
Carbamazepine
N-(2-(Carbamoyloxy) propyl) -N, N, N-trimethylammonium hydroxide
Carbenicillin
Carbenoxolone
Carbetocin
Carbidopa
Carbimazole
Carbocistein
Carboplatin
Carbromal
Carbuterol
Carfecillin
Carglumic acid
Carindacillin
Carisoprodol
Carmustin
L-Carnitine
-for parenteral administration-
Carprofen
Carteolol
Carvedilol
Carzinophillin
Caspofungin
Catalase
Cefacetril
Cefaclor
Cefadroxil
Cefalexin
Cefalonium
-for use in animals,
Cefaloridin
Cefalotin
Cefamandol and its esters
Cefapirin
Cefapirin Benzathin (2: 1)
-for use in beef and veal
Cefazedon
Cefazolin
Cefepim
Cefetamet and its esters
Cefixim
Cefmenoxim
Cefodizim
Cefoperazon
Cefotaxim
Cefotetan
Cefotiam
Cefovecin
-for use in animals,
Cefoxitin
Cefpodoxim and its esters
Cefquinom
Cefradin
Cefsulodin
Ceftarolinfosamil and its esters
Ceftazidim
Ceftibuten
Ceftiofur
Ceftizoxim
Ceftriaxone
Cefuroxim and its esters
Celecoxib
Celiprolol
Certoparin
-for parenteral administration-
Ceruletid
Cetrorelix
Chenodesoxycholic acid
Chenopodii anthelminthici, Oleum
Quinidine
Chinin
-for human use,
Chloralformamide
Chloralhydrate
Chloralose
Chlorambucil
Chloramphenicol and its esters as well as their compounds
Chlorcyclizine
Chlorisondamine
Chlormadinon and its esters
Chloromethaqualone
Chloromethine
Chloromethin-N-oxide
Chlormezanon
Chlornaphazine
Chloroform
-with the exception of preparations for external use in a concentration of up to 50% by weight,
Chloroprocaine
Chloroquine
Chlorothiazide
Chlorotrianises
Chlorpropamide
Chlorprothixen
Chlortalidone
Chlortetracycline
Chlorzoxazon
Chondroitinpolysulphate
-for parenteral administration-
Choriogonadotropin alfa
Chorionic gonadotrophin (human alpha-subunit protein reduced)
Chorionic gonadotrophin (human beta-subunit protein reduced)
Cholic acid
Chorionic gonadotrophin
Chrysoidin
Chymopapain
-for parenteral administration-
Ciclacillin
Ciclesonide
Cicletanin
Ciclonium salts
Ciclopirox
-except for outside use in adults and school children-
Ciclosporin
Cidofovir
Cilazapril
Cilostazol
Cimetidine
Cimicoxib
-for use in animals,
Cinacalcet
Cinchocain
Cinchophen and its esters
Cinnarizin
Cinoxacin
Ciprofloxacin
Cisapride
Cisatracurium salts
Cisplatin
Citalopram
Cladribin
Clanobutin
-for use in animals,
Clarithromycin
Clavulanic acid
Clenbuterol
Clevidipine
Clidinium bromide
Clindamycin and its esters
Clioxanid
Clobetasol-17-propionate
Clobetasonbutyrate
Clocortolon and its esters
Clodronic acid
Clofarabine
Clofazimin
Clofenamide
Clofezon
Clofibric acid and its esters
Clomethiazole
Clomifen
Clomipramine
Clonidine
Clopamide
Clopenthixol and its esters
Clopidogrel
Clopidol
Cloprednol
Cloprostenol
-for use in animals,
Clorexolon
Clorindion
Closantel
-for use in animals,
Clostebol and its esters
Clostridium botulinum neurotoxin type A (free of complexing proteins)
Clostridium botulinum Toxin Type A and B
Clotrimazole
-except for external use,
-except for vaginal use in pack sizes of up to 600 mg clotrimazole, distributed up to 3 single doses, and for an application period of up to 3 days,
Cloxacillin
Clozapine
Cobicistat
Caffeine
-in preparations containing one or more of the following analgesically active substances

a)

Paracetamol

b)

Pyrazolone derivatives

c)

Salicylic acid derivatives

(except in single doses up to 0.5 g and a total quantity of up to 10 g per pack for the analgesic active substances)
-in preparations for the treatment of the primary apnea in premature infants,
Colchici flos, semen et tuber and their preparations
Colchicumalkaloids, also hydrogenated
Colecalciferol
-except in preparations

a)

for use in human beings, provided that a daily dose of up to 1 000 IU is available on containers and outer envelopes. (equivalent to 0.025 mg) Colecalciferol is indicated,

b)

for use in animals, provided that a daily dose of up to 10 000 IU is available on containers and outer envelopes. (equivalent to 0.25 mg) Colecalciferol is indicated-

Colesevelam
Colestilan
Colestipol
Colestyramine
Colistimethat-sodium and other colistimethat-salts
Colistin
Colocynthidis fructus and its preparations
Conii herba and its preparations
-except for external use in plasters, ointments and similar preparations and as additives to be softened-
Coniin
Convallaria-Glykoside
Corifollitropin alfa
Corticorelin from man
Corticotropin, also functional parts
Cortison and its esters
Coumafos
-except for external use,
Crizotinib
Cropropamide
-except preparations

a)

for use in human beings, provided that they do not contain more than 25 mg per piece of medicinal product, not more than 75 mg per millilitre for injection, per piece of injection,

b)

for use in animals, provided that they do not contain more than 75 mg per millilitre in oral or nasal preparations,

Crotonis oleum
Crotonis semen and its preparations
Crufomat
Curare and its preparations
Cyacetacid
Hydrogen cyanide
-except as a stabiliser in preparations for oral and parenteral use in daily doses up to 100 my g, based on the cyanide content,
Cyclodrin
Cyclofenil
Cyclopenthiazid
Cyclopentolate
Cyclophosphamide
Cycloserine
Cyclothiazide
Cyproheptadin
Cyproteron and its esters
Cytarabine
Cytisin

Dabigatran and its esters
Dabrafenib
Dacarbazine
Dactinomycin
Dalfopristin
Dalteparin
-for parenteral administration-
Danaparoid
Danazol
Danofloxacin
-for use in pig, beef and chicken
Dapagliflozin and its esters
Dapiprazole
Dapoxetine
Dapson
Daptomycin
Darbepoetin alfa
Darifenacin
Darunavir
Dasatinib
Datura species and their preparations
-with the exception of homeopathic preparations for oral use from above-ground parts of Datura stramonium in the flowering period, which are manufactured in accordance with the manufacturing rules 25 and 26 of the homeopathic medicinal book,
Daunorubicin
Deanol
-with the exception of preparations, provided that a daily dose of up to 50 mg, calculated as Deanol, is indicated on containers and outer envelopes,
Decitabin and its esters
Deferasirox
Deferipron
deferoxamine
Defibrotid
Deflazacort
Defosfamide
Degarelix
Delapril
Delmadinon and its esters
Dembrexin
-for parenteral use in animals,
Demecariumbromide
Demeclocyclin
Demecolcin
Demegeston
Demelverin
Denaverin
Depreotide
Desfluran
Desipramin
Desirudin
desloratadine
Deslorelin
-for use in animals,
desmeninol
desmopressin
desogestrel
desonid
Desoximetason
Desoxycorton, its esters and glucoside compounds
Destomycin A
-for use in animals,
Detajmiumbitartrate
Detomidine
-for use in bovine animals and horses,
Dexamethasone and its esters
-except dexamethasone dihydrogen phosphate for single parenteral use in aqueous solution in ampoules/pre-filled syringes containing 40 mg of active substance and up to a maximum of 3 pack units (equivalent to 120 mg of active substance) for emergency treatment of severe Anaphylactic reactions in humans after neural therapy up to the arrival of the rescue service-
Dexibuprofen
Dexketoprofen
Dexmedetomidine
-for use in dogs and cats,
Dexrazoxan
Dextrane
-for intravenous use-
Dextrofemin
Dextrothyroxine
Diacetylnalorphine
Diacetylsplenopentin
4,4 '-diamino-2,3', 5 ', 6-tetraiododiphenyl sulfone
Diazoxide
Dibekacin
Dibenzepine
N, N-Dibenzyl-N-(2-chloroethyl)-amine
dibotermin alfa
1,2-Dibromomethane
1,1-dichloroethane
1,2-dichloroethane
Dichlorvos
Diclazuril
-for use in the case of sheep,
Diclofenac
-except for cutaneous use in concentrations of up to 5% except for thrombophlebitis superficialis and actinic keratosis.
-except in the case of oral administration for mild to moderate pain and fever, at doses up to 25 mg per unit divided and a daily dose of 25 to a maximum of 75 mg for a maximum period of application of three (antipyresis), or four (Analgesie) days-
diclofenamide
dicloxacillin
Dicoumarol
Dicyclanil
-for use in the case of sheep,
Didanosine
Dienestrol
Dienogest
Diethylcarbamazin
1-(2-(2-(diethylmethylazaniumyl) ethoxy) ethyl) -1-methylpyrrolidinium diiodide
Diethyl-p-nitrophenyl phosphate
Diethylstilbestrol
Diflorasone-17, 21-diacetate
Difloxacin
-for use in chicken, dog, turkey and beef,
Diflucortolon and its esters
Diflunisal
Digitalis folium, glycoside-containing and its preparations
Digitalis active ingredients, genuine and partially degraded glycosides
-except for the use of digitoxin for external use, provided that a daily dose of up to 0.0015 g is indicated on containers and outer sheaths,
N-(2 ,3-dihydro-1,4-benzodioxin-2-ylmethyl) -3-methoxypropan-1-amine
Dihydralazine
Dihydrocuprein and its derivatives
Dihydroergocornin
Dihydroergocristin
Dihydroergocryptin
Dihydroergotamine
1,1-Dioxo-3-(2-phenylethyl) -6-trifluoromethyl-3,4-dihydro-2H-1 lambda (high) 6,2,4-benzothiadiazine-7-sulfonamide
Dihydrostreptomycin
Dihydrotachysterol
Dilazep
Diltiazem
Dimepranol (4-acetamidobenzoate)
Dimenhydrinate
-for parenteral administration-
2,3-Dimercapto-1-propanesulfonic acid
Dimetacrine
Dimetamfetamine
Dimethisteron
Dimethocaine
(3-dimethylamino-2-hydroxypropyl)-(4-propylaminobenzoate)
4-Dimethylaminophenol
O-(4-Dimethylsulfamoylphenyl) -O ', O ''-dimethylthiophosphate
0,0 '-dimethyl-0' '-(4-sulphamoylphenyl) thiophosphate
Dimethyl fumarate
-for oral use-
Dimethyl sulphoxide
-except for cutaneous use in humans in a concentration of up to 15%-
Dimethyltubocurarin
Dimetinden
-for parenteral administration-
dimetridazole
-for use in animals,
Dinoprost
Dinoproston
Diphenhydramine
-for parenteral administration-
Di (L-(+)-ornithine)-(2-oxoglutarate)-hydrate-diphosphonic acid
-as a carrier substance for ((high) 99m Tc) technetium
3,3-Diphosphono-1,2-propanedicarboxylic acid-as a carrier substance for ((high) 99m Tc) technetium
Dipiproverine
Dipivefrin
Dipyridamole
Dirlotapid
-for use in animals,
Disopyramide
Distigmin
disulphram
Dithranol
Dobutamine
Docetaxel
Dofetilid
Dolasetron
Domperidone
Donepezil
Dopamine
Dopexamine
Doramectin
-for use in bovine, ovine and porcine animals,
Doripenem
Dornase alfa
Dorzolamide
Dosulepin
Doxapram
Doxazosin
Doxepin
Doxorubicin
Doxycycline
Droloxifen
Dronedaron
Dropempin
Droperidol
Drospirenone
Drostanolon and its esters
Duloxetine
Dutasteride
Dydrogesterone

Ebastin
Econazole
-except for external use,
Ecothiopat
Edoxudin
Efavirenz
Eflornithine
Iron (III)-hexacyanoferrate (II)
Iron connections
-for parental use, except for the prophylaxis of iron deficiency anaemia in suckling piglets, provided that this is indicated as the sole scope of application on containers and outer sheaths,
Eletriptan
Eltrombopag
Elvitegravir and its esters
Emedastin
Emepronium salts
Emetin
Emtricitabine
Emylcamat
Enalapril
Enalaprilat
Endomid
Enfluran
Enfuvirtide
Enoxacin
Enoxaparin
-for parenteral administration-
Enoximon
Enrofloxacin
-for use in animals,
Entacapone
Entecavir
Enzalutamide
Enzymes, proteolytic, animal or vegetable origin
-for parenteral administration-
Ephedra-species and preparations of Ephedra species
-for oral use, with the exception of homeopathic preparations of Ephedra in higher dilutions other than D1 and other than in homeopathic preparations manufactured in accordance with the manufacturing rules 25 and 26 of the homeopathic medicinal book are-
Ephedrine
-for oral use

a)

in preparations to which only this substance or substance, together with caffeine, is added as an active ingredient,

b)

in other preparations, provided that a single dose of more than 10 mg or, in the case of prolonged-release preparations, has a daily dose of more than 40 mg, calculated as ephedrine base, or caffeine preparations in other preparations, included-

Epicillin
Epimestrol
Epinastin
Epinephrine
-excluding autoinjectors in pack sizes of one unit for single parenteral use for the emergency treatment of severe anaphylactic reactions in humans after neural therapy until the rescue service is received-
Epirubicin
Eplerenon
Epoetin alfa, beta, delta, theta and zeta
Epoetin alfa, beta, delta, theta and zeta
Epoprostenol and its derivatives
Eprazinone
Eprinomectin
Eprosartan
Eptifibatide
Eptotermin alfa
Erdostein
Ergocalciferol,
-except preparations

a)

for use in human beings, provided that a daily dose of 1 000 IU of ergocalciferol is indicated on containers and outer envelopes,

b)

for use in animals, provided that a daily dose of up to 10 000 IU of ergocalciferol is indicated on containers and outer envelopes,

Eribulin and its derivatives
Eritrityl tetranitrate and other nitrates derivatives of erythritol
Erlotinib
Dietary solutions using carbohydrates, calorie-containing sugar substitutes, fat emulsions or glucogenes or ketogenic amino acids
-for parenteral administration-
Ertapenem
Erythromycin and its esters
Escherichia coli, alive
-for oral use in animals,
Esketamine
Eslicarbazepine and its esters
Esmolol
Esomeprazole
-except for the treatment of heartburn and acid discharge in a single dose of 20 mg and in a maximum daily dose of 20 mg for a maximum period of 14 days and a maximum pack size of 280 mg of active substance,
Estradiol and its esters
Estramustin-17-dihydrogen phosphate
Estriol
Estrogens, conjugated
Etacrynic acid
Etafenon
Etamsylat
in animals,
Etanercept
Etaqualon
Ethadione
Ethambuto l
Ethiazid
Ethinylestradiol and its esters
Ethionamide
Ethisterone
Ethosuximide
6-ethoxy-2-benzothiazolesulfonamide
Ethyl benzhydramine
Coumessiacetic acid and its esters
Ethylestrenol and its esters
2-ethylhex-2-enal
-for use in animals,
Ethyl hydrogen fumarate
-for oral use-
Ethyl nitrate
Etidocaine
Etidronic acid
Etiproston
-for use in bovine animals,
Etiroxate
Etodolac
Etodroxizin
Etofenamat
-except for external use,
Etofibrat
Etofyllinclofibrat
Etoloxamine
Etomidat
Etonogestrel
Etoposid
Etoricoxib
Etozoline
Etravirine
Etretinate
Etynodiol and its esters
Everolimus
Exametazim
Exemestan
Exenatide
Ezetimib
Famciclovir
Famotidine
-except in solid oral preparations, in a concentration of up to 10 mg per divided form and in pack sizes of up to 140 mg, provided that the application for adults and children is completed at 16. The term "short-term use for heartburn and/or acid impact" and for a maximum duration of 14 days is limited to the application areas "for short term use".
Fampridine
Febantel
-for use in animals,
Febuprol
Febuxostat
Felbamat
Felodipine
Fenbendazole
-for use in animals,
Fenbufen
Fenbutrazat
Fenclofos
Fendilin
Fenfluramin
Fenofibrat
Fenoprofen
Fenoterol
-except for emergency tokolysis in preparations of 25 my g for dissolution in 4 ml solution for infusion for slow (over 2-3 minutes) bolus injection in a pack size of up to 5 ampoules for delivery to midwives and debindment plasters for the Practical requirements-
Fenprostals
-for use in animals,
Fenthion
Fentonium bromide
Fenyramidol
Fertirelin
-for use in animals,
Ferucarbotran
-for the representation of herd-shaped liver damage in magnetic resonance tomography (MRI)-
Ferumoxytol
Fesoterodine
Fexofenadin
Fibrinolysin (human)
Fidaxomicin and its derivatives and analogues
Filgrastrim
Filicis rhizoma and its preparations
Finasteride
Fingerolimod and its derivatives
Firocoxib
-for use in animals,
Flecainid
Fleroxacin
Flomoxef
Flopropion
Florfenicol
Fluanison
Flubendazole
-for use in animals,
Flucloxacillin
Fluconazole
Flucytosine
Fludarabine 5 '-dihydrogen phosphate
Fludeoxyglucose ((high) 18F)
Fludrocortisone and its esters
Fludroxycortide
Flufenamic acid
-except for the cutanic application,
Flumazenil
Flumetason and its esters
Flumethrin
-for use in beef and veal
Flunarizin
FlunIsold
Flunixin
-for parenteral use in animals,
-for use in dogs,
Fluocinolonacetonide
Fluocinonide
Fluocortin-butyl
Fluocortolon and its esters
Fluorescein
-for parenteral administration-
fluorides, soluble,
-unless a daily dose equivalent to a fluorine content of up to 2 mg is given on containers and outer envelopes,
-except in preparations as a gel for local use on the teeth in pack sizes of up to 25 g, provided that containers and outer coverings indicate that the application is intended for adults and children from the age of 6. It is limited to one single dose per week, corresponding to a fluorine content of up to 7 mg,
Fluorometholone and its esters
Fluorouracil
Fluorophenylalanine
Fluostigmin
Fluoxetine
Fluoxymesterone and its esters
Flupentixol
Flupirtine
Flupredniden and its esters
Fluprostenol
-for use in animals,
Industrial Biprofen
-except for oral and pharyngeal use for short-term symptomatic treatment in painful inflammation of the oral and pharynx mucosa in a maximum daily dose of 50 mg-
River Piriles
Flutamide
Fluticasone and its esters
Fluvastatin
Fluvoxamine
Folic acid
-for parenteral administration in the treatment of cancer or rheumatic diseases,
Follitropin
Follitropin alfa and beta
Fomepizole
Fomintop
Fomivirsen
Fomocain
-with the exception of medicinal products for application to the skin or mucosa, except for use in the eye,
Fondaparinux
Formestan
Formocortal
Formoterol
Fosamprenavir
Fosaprepitant
Foscarnet
-for cutaneously and parenteral administration-
Fosfestrol
Fosfomycin
Fosinopril
Framycetin
Frovatriptan
Fulvestrant
Furaltadon
Furazolidone
Furosemide
Fusidic acid and its ester gabapentin
Galantamine
Gallamin
Gallopamil
Gamithromycin
-for use in animals,
ganciclovir
Ganirelix
Gatifloxacin
Gaxilose
Gefitinib
Gelsemii rhizoma and its preparations
-except in homeopathic preparations for oral use produced in accordance with the rules 25 and 26 of the homeopathic medicinal book,
Gemcitabine
Gemeprost
Gemfibrozil
Gentamycin
Gene transfer-medicinal product
Gepefrin
Gestodes
Gestonoron
Tissue grafts, human allogenes and tissue engineered products
Gitoformat
Glafenin
Glatiramer
Glibenclamide
Glibornurid
Gliclazide
Glimepiride
Glipizid
Gliquidon
Glisoxepid
Glucagon
Glucametacin
Glucosamine
-except for oral use-
Glyceroltrinitrate
Glycopyrronium bromide
Glymidin
Gold-Keratin-Complex
Gonadorelin
Gonadorelin (6-D-Phe) acetate
-for use in animals,
Gonadotrophin (human and horse desertion)
Goserelin
Granisetron
Grepafloxacin
Griseofulvin
Green tea leaves dry extract (purified dry extract from Camellia sinensis (L.) O. Kuntze (45-56: 1), corresponding to 55-72% (-)-Epigallocatechin-3-(3,4,5-trihydroxybenzoate))
Guanabenz
Guanaclin
Guanethidine
Guanfacin
Guanidine, also bound to protein
Guanoxane
Gutti and its ready-to-use halcinonide
Halofantrine
Halofuginone
-for use in animals,
Halometason
Haloperidol and its esters
Halothan
Haloxon
((high) 13C) urea
((high) 14C) urea
Hemoglobinglutamer
-for use in animals,
Heparine
-for parenteral administration-
Hetacillin
hexachloroethane
-for use in animals,
Hexachlorophen
-except for external use in a concentration of up to 1% by weight,
Hexacyclonic acid
Hexamethonium salts
Hexcarbacholine bromide
Hexobendin
Hexoprenaline
Hexyl (5-amino-4-oxopentanoate)
Histamine
-except

a)

Preparations for oral use, provided that they contain no more than 0.4 mg of histamine salt per gram or millilitre and should be taken dropwise,

b)

Preparations for external use-

Histrelin
Homatropin
Human plasma proteins with factor VIII inhibitor bypass activity
Human plasma proteins with factor VIII corrective activity
Hyaluronic acid
-for intraarticular use-
-for intravenous use in horses,
Hydantoin and its derivatives
-excluding Allantoin-
Hydralazine
Hydrastinin
Hydrastiswurzelstock and its preparations
-with the exception of preparations containing no more than 1.21 mg of Hydrastic alkaloids, calculated as Hydrastin, per millilitre, for application to the oral mucosa,
-except in homeopathic preparations for oral use produced in accordance with the rules 25 and 26 of the homeopathic medicinal book,
Hydrochlorothiazide
Hydrocortisone and its esters
-except in preparations for external use

a)

in a concentration of up to 0.25% hydrocortisone or hydrocortisone acetate, calculated as base and in pack sizes up to 50 g, and

b)

In a concentration of more than 0.25 to 0.5% hydrocortisone or hydrocortisone acetate, calculated as base and in pack sizes up to 30 g for the short term (maximum two weeks) external use for the treatment of moderately pronounced Inflammatory, allergic or itchy skin diseases,

and provided that there is a restriction of use on both adults and children on containers and external envelopes from the age of 6. Year of age is indicated-
Hydroflumethiazid
Hydroxocobalamin
-for the treatment of a known or suspected cyanide poisoning-
Hydroxycarbamide
8-hydroxyquinaldines, halogenated and their esters
-except for use in the oral cavity, provided that a daily dose of up to 20 mg is given on containers and outer envelopes, and for external use,
8-hydroxyquinolines, halogenated and their esters
-except for external use,
Hydroxychloroquine
Hydroxydione and its esters
17ß-hydroxy-17-methylestr-4-en-3-one (methylestraone)
Hydroxyprogesterone
Hydroxystilbamidine
Hydroxyzine
Hygromycin A
Hyoscyami folium et herba and their preparations
-except for external use,
Hyoscyamin
Hypophysis lags and their preparations
Hypromellose
-for use in the opened eye -Ibafloxacin
Ibandronic acid
Ibuprofen
-except for external use in a concentration of up to 5% by weight,
-except for oral use without the addition of any other active substance in a concentration of up to 400 mg per divided form and in a daily dose up to 1 200 mg for mild to moderate pain and fever,
-except in solid preparations for rectal use as monopreparates in individual doses up to 10 mg/kg body weight (up to a maximum single dose of 600 mg per form divided) and in a daily dose up to 30 mg/kg body weight (up to at a maximum daily dose of 1 800 mg) in mild to moderate pain and fever,
-except for oral use in liquid preparations without the addition of further active substances for adults and children from 6 months of age in individual doses up to 10 mg/kg body weight (up to a maximum daily dose of 1 200 mg) mild to moderate pain and fever-
-except for oral use in doses up to a maximum of 400 mg per divided form and at a maximum daily dose of 1 200 mg, for rectal use in solid preparations as a single dose of single doses up to 10 mg/kg of body weight up to the maximum A single dose of 600 mg per divided form and up to a maximum daily dose of 30 mg/kg body weight, respectively. 1 800 mg, for the treatment of acute headache in migraine with or without aura
-except for oral administration (at maximum single dose of 400 mg and at a maximum daily dose of 1 200 mg) in combination with pseudoephedrine hydrochloride (at a maximum single dose of 60 mg and at a maximum daily dose of 180 mg), with an amount of active substance of up to 720 mg of pseudoephedrine and 4 800 mg of ibuprofen per pack, for the treatment of acute rhinosinusitis in connection with other cold symptoms (such as: (e. g. fever and pain)-
Icatibant
Idarubicin
Idoxuridine
Idursulfase
Ifos famid
Iloprost
Imatinib
Imepitoin
-for use in animals,
Imiclopazin
Imidapril
Imiglucerase
Imipenem
Imipramin
Imiquimod
Imolamine
Vaccines
-for use on or in the human body, without prejudice to the provisions of the Animal Vaccine Regulation on prescription.
Indacaterol
Indapamide
Indinavir
Indocyanine gland
Indometacin
-except for the cutanic use in 1% solution-
Indoramin
Indoxacarb
-for use in animals,
Ingenolmebutat and its esters
myo-Inositolhexanitrat
Inproquon
Insulin, further products manufactured from the pancreas and intended for injections in diabetes mellitus
Insulin aspart
Insulin defalan (from beef)
Insulin degludec
Insulin detemir
Insulin glargin
Insulin glulisine
Insulin lispro
Insulin (from pig)-zinc suspension for injection, crystalline
-for use in animals,
Interferons
Intrauterinpessare
-on the prevention of pregnancy,
Iodethan
Iodine solutions and preparations of iodine for the production of iodine solutions
-except for external use,
-except in preparations for internal use in animals, if the ready-to-use solution does not exceed 5% of iodine,
Iodine sulphur
-except for external use,
Iosarcol
Iotrolan
-for intravascular use-
Ipecacuanhae radix and its preparations
Ipratropium bromide and its esters
Iprazochrom
Iproclozid
Ipronidazole
-for use in animals,
Irbesartan
Irinotecan
Isoaminil
Isocarboxazide
Isoconazole
-except for external use,
Isoetarin
Isoflurane
Isonicotinaldehyde and its derivatives
Isonicotinic acid hydrazide and its derivatives
Isoprenaline
-with the exception of preparations for external use in a concentration of up to 0.5% by weight,
Isopropamidiodid
Isosorbide dinitrate
Isosorbide mononitrate
Isotretinoin
Isradipin
Itraconazole
Ivabradine
Ivacaftor
Ivermectin
-for use in animal Jalapae resina et tuber and their preparations
Johanniskraut
-for the treatment of moderate depression,
Josamycin and its Esterpotassium
-for parenteral use in concentrations of more than 6 mmol/l-
Potassium bromide
-for systemic use-
Potassium dichromate
Kanamycin
Kava-Kava-rootstock and its preparations
-with the exception of homeopathic preparations for oral use produced according to the method of preparation 26 of the homeopathic pharmacopoeia,
Kavain
Kebuzon
ketamine
Ketanserin
-for use in animals,
Ketoconazole
-except for external use,
Ketoprofen
Ketorolac
-for use in the eye,
Ketotifen
-except for use in the eye at a concentration of up to 0.025%-
Kitasamycin
Collagen
-for injection-
Contrast medium
-for use in X-ray, magnetic resonance imaging or ultrasonic diagnostics,
Creosote
-except preparations for external use in a concentration of up to 50% by weight -Labetalol
Lacidipine
Lacosamide
Lactobacillus salivarius
Lactucavirosa-preparations
Lamivudine
Lamotrigine
Lanreotide
Lansoprazole
Lapatinib
Laronidase
Lasofoxifene and its esters
Latamoxef
Latanoprost
Lecirelin
-for use in animals,
Leflunomide
Lenalidomide
Lenograstim
Lepirudin
Lercanidipine
Lespedeza capitata and its preparations
Letrozole
Leuprorelin
Levallorphan
Levamisol
Levetiracetam
Levobunolol
Levobupivacain
Levocetirizine
Levodopa
Levodropropizin
Levofloxacin
Levofolinic acid
Levonorgestrel
-except in preparations for oral use without the addition of other active substances in a concentration of up to 1.5 mg of active substance per unit of medicinal product and in packs with a maximum active substance content of 1.5 mg Emergency contraception-
Levosimendan
Lidocaine
-with the exception of medicinal products for parenteral use, without the addition of other active substances in a concentration of up to 2% for intracutaneous use in healthy skin in the context of neural therapy,
-with the exception of subcutaneous and intramuscular infiltration anaesthesia for the performance of dam sections and for the sewing of dyed incisions and lambs at birth in a concentration of up to 1%, a single dose of up to 10 ml and a quantity of up to 10 ml per ampoule for the delivery of midwives and debindment pens in the course of their professional practice,
-with the exception of medicinal products for application to the skin or mucosa, except

a)

for the use of the eye and the external ear canal,

b)

to relieve neuropathic pain after a herpes zoster infection (post-zoster neuralgia)-

Lidoflazine
Linaclotid
Linagliptin
Lincomycin
Lindan
Linezolid
Lipegfilgrastim
Liraglutide
Lisinopril
Lisurid
Lithium
-for the treatment of mental illness and psychosis,
Lixisenatide
Lobeliae herba and its preparations
-except for smoking and smoking,
Lobelin
Lofepramin
Lomefloxacin
Lomitapid
Lomustin
Lonazolac
Loperamide
-except in solid oral preparations for acute diarrhoea in daily doses up to 12 mg and in pack sizes up to 24 mg, provided that the use of the containers and the outer packaging is indicated by the use of adults and children as from completed 12. Year of life is limited to
Loperamidoxide
Loracarbef
Lorcainid
Lornoxicam
Losartan
Loteprednol
Lovastatin
Loxapine
Lufenuron
-for parenteral use in dogs and cats,
Lumefantrin
Lumiracoxib
Luprostiol
-for use in animals,
Lutropin
Lutropin alfa
Lynestrenol
(RS) -3-methyl-2-oxopentanoic acid
3-methyl-2-oxobutanoic acid
4-methyl-2-oxopentanoic acid

MACI (matrix-induced autologous chondrocyte implantation)
Macrogol
-for the treatment of the coprovase in children and adults-
Macrogollaurylether (Polidocanol)
-for sclerotherapy of varices and brooms,
Mafenid and its compounds
Magnesium bis (hydrogen aspartate) dihydrate
-for intracoronary use-
Mandragora officinarum L. and Mandragora autumnalis Bertol, roots of and their preparations
-except for external use,
-with the exception of homeopathic preparations for oral use produced in accordance with the provisions of Regulations 25 and 26 of the Homeopathic Pharmacopoeia
Mangafodipir
Manidipine
Mannitolhexanitrate
Mannomustin
Maprotilin
Maraviroc
Marbofloxacin
Maropitant
-for use in animals,
Masitinib
-for use in animals,
Mavacoxib
-for use in animals,
Mazipredon
Mebendazole
Mebeverine
Mebhydrolin
Mecamylamine
Mecasermin
Meclocyclin
Meclofenamic acid
-for use in animals,
-except for use in horses,
Meclozin
Medetomidine
Medrogeston
Medroxyprogesterone and its esters
Medryson and his esters
Mefenamic acid
Mefloquin
Mefruside
Megestrol
Melagatran
Melatonin
Melitracen
Meloxicam
Melperon
Melphalan
Memantine
Mepacrin
Mephenesin
MephenDate
Mepindolol
Mepivacain
Meproscillarin
Meptazinol
Mequinol
Mercaptamine
Mercaptopurine
Meropenem
Mertiatide-as a carrier substance for ( ^99m Tc) Technetium-
Mesalazine
Mesna and other salts of 2-sulphanylethanesulphonic acid
Mesterolon and its esters
Mestranol
Mesuximide
Metaclazepam
Metacycline
Metamfepramon
Metamizol
Metandienon and its esters
Metaraminol
Metaxalon
Metenolon and its esters
Metergolin
Metformin
Methacholine
Methallenestril
Methandriol and its esters
Methanthelinium bromide
Methazolamide
Methocarbamol
Methotrexate
Methoxamine
Methoxsalen
Methoxyfluran
Methyclothiazide
Methyl (5-amino-4-oxopentanoate)-hydrochloride
Methyldopa
DL-methyldopa
Methylergometrin
-except for use in post-birth haemorrhage in a concentration up to 0.3 mg/ml and a single dose up to 1 ml for delivery to midwives and debindment plasters for practical use,
Methylnaltrexonium salts
Methylpentynol and its esters
2-methyl-1-phenylbut-3-in-1,2-diol
Methylprednisolone and its esters
N-Methylscopolaminium salts
Methylsulfonal
Methyltestosterone and its esters
Methylthioninium salts
-for parenteral use in humans,
Methysergid and its esters
Meticillin
Metildigoxin
Metipranolol
Metoclopramide
Metolazon
Metomidate
Metoprolol
Metrifonate
Metronidazole and its esters
Metyrapon
Metyridine
Mexican
Mezlocillin
Mianserin
Micafungin
Miconazole
-except for external use and for use in the oral cavity,
-except for vaginal use in pack sizes of up to 1 043 mg miconazole and for an application period of up to 3 days-
Microbial collagenase
Midodrin
Mifamurtid and its esters
Mifepriston
Miglitol
Miglustat
Milrinon
Miltefosin
Minocycline
Minoxidil
-except for topical application in androgenetic alopecia in a concentration of up to 5%-
Mirabegron and its derivatives
Mirtazapine
Misoprostol
Mitomycin
Mitotan
Mitoxantron
Mitratapid
Mivacurium salts
Mizolastin
Moclobemide
Modafinil
Moexipril
Mofebutazone
Molgramostim
Molsidomin
Mometason and its esters
Monepantel
-for use in animals,
Monobenzon
Montelukast
Moperon
Morantel
-for use in animals,
Morazon
Moroxydine
Moxestrol
Moxidectin
Moxifloxacin
Moxonidine
Mupirocin
Mycophenolic acid
Myrtecain
-with the exception of medicinal products for application to the skin or mucosa, except for the application to the eye Nabumeton
Nadroparin
-for parenteral administration-
Nifurstyric acid-for use in animals-
Nadifloxacin
Nadolol
Nafarelin
Nafcillin
-for use in animals,
Naftalofos
Naftidrofuryl
Nalbuphin
Nalidixic acid and its esters
Nalmefen and its esters
Nalorphine
Naloxone
Naltrexon
Naproxen
-except in solid preparations for oral use without the addition of other active substances in a concentration of up to 250 mg per divided form and in a daily dose of up to 750 mg and in a pack size of up to 7 500 mg Use in adults and children from 12 years of age in mild to moderate pain and fever.
Naratriptan
-except for the treatment of migraine headache in adults between 18 and 65 years of age, after initial diagnosis of migraine by a doctor, in solid preparations for oral use in concentrations up to 2.5 mg per divided form, and in a total quantity of 5 mg per pack,
Natamycin
-except for external use,
Nateglinide
Sodium aurothiomalate
Sodium-gold chloride
Sodium nitrite
Nebivolol
Nedocromil
-except for use in seasonal allergic rhinitis-
-except for use in the eye,
Nefazodone
Nefopam
Nelarabine
Nelfinavir
Neodymium 3-sulfoisonicotinate
Neomycin
Neostigmine salts
Nepafenac
Netilmicin
Nevirapine
Nicarbazin
-for use in animals,
Nicardipine
Nicergolin
Niclofolan
Nicotin
-except for oral (including oral inhalation) use without the addition of other active ingredients in a quantity

a)

up to 150 mg of nicotine per dosage form, the single dose being 1 mg of nicotin, and up to 64 mg in a daily dose, or

b)

up to 15 mg nicotine per dose of medicinal product and in a daily dose up to 64 mg-

-except for transdermal use as plaster without the addition of other active substances in a concentration of up to 52.5 mg of nicotine per dosage of medicinal product, respectively. even at higher concentrations, provided that the release of the active substance is not exceeded by an average of 35 mg of nicotin per 24 hours,
-except for the combination of transdermal use with oral (including oral inhalation) use up to a maximum daily dose of 64 mg-
Nifedipine
Nifenalol
Niflumic acid
Nifuratel
Nifurpirinol
Nifurprazine
Nilotinib
Nilutamide
Nilvadipin
Nimesulide
-for use in animals,
Nimodipine
Nimorazole
Nimustin
Niridazole
Nisoldipine
Nitisinone
Nitrendipine
Nitrofural
Nitrofurantoin
Nitrofurathiazide
-for use in animals,
Nitroprussidnatrium
-for intravenous use-
Nitroscanate
-for use in animals,
Nitroxinil
Nitroxolin
Nizatidine
Nomegestrol and its esters
Nomifensin
Norelgestromin
Norepinephrine
-except in ointments for external use-
Norethisteron
Noretynodrel
Norfloxacin
Norgestimat
Norgestrel
Noryesterday
Nortestosterone and its esters
Nortriptylin
Noscapin
Novobiocin
Noxiptilin

Obidoxim
Oclacitinib
-for use in animals,
Octreotide
Oil of deep sea fish (with specified composition)
-for parenteral nutrition-
Ofloxacin
Olanzapine
Oleander glycosides
Oleandomycin
Olmesartan and its esters
Olodaterol
Olopatadin
Olsalazine
Omega-3-acid ethyl ester
-for adjuvant treatment for secondary prophylaxis after myocardial infarction, in addition to standard treatment (e.g. B. Statine, platelet aggregation inhibitors, beta-blockers, ACE inhibitors)-
Omeprazole
-except for the treatment of heartburn and acid discharge in a single dose of 20 mg and in a maximum daily dose of 20 mg for a maximum period of 14 days and a maximum pack size of 280 mg of active substance,
Ondansetron
Opipramol
Opium alkaloids
-in so far as the prescription and tax are not regulated by the annexes of the Narcotics Act, in the current version,
Orazamid
Orbifloxacin
Orciprenalin
Orphenadrin
Orgotein
Orlistat
-not authorised by the European Commission, non-prescription medicinal products for oral use with a maximum dose of 60 mg per divided form and medicinal products for oral use with a maximum dose of 60 mg per dose. divided form and a maximum daily dose of 180 mg-
Ornidazole
Osateron and its esters
Oseltamivir
Osmium acid
Osteogenous Protein 1
Oxabolon and its esters
Oxaceprol
Oxacillin
Oxaliplatin
Oxaprocin
Oxatomid
Oxcarbazepine
Oxetacaine
Oxfendazole
-for use in animals,
Oxiconazole
-for vaginal use-
Oxideic acid
-as a carrier substance for ((high) 99m Tc) technetium
Oxitriptan
Oxitropium bromide
Oxolin
Oxoleic acid
2-Oxo-3-phenylpropanoic acid
Oxprenolol
Oxybuprocain
Oxybutynin
Oxyclozanide
Oxymesterone and its esters
Oxymetholone
Oxypertin
Oxyphenbutazone
Oxyphencyclimin
Oxyphenisatin and its esters
Oxytetracycline and its compounds
Oxytocin
-except for use in post-birth haemorrhages in a concentration of up to 10 IU/ ml and a single dose of up to 1 ml for the delivery of midwives and debinding plasters for the practical use of 4-phenylbutanoic acid
Paclitaxel
Palifermin
Palonosetron
Pamidronic acid
Pancuronium bromide
Pantoprazole
-with the exception of medicinal products in pack sizes of no more than 14 divided units in a single dose of 20 mg and in a maximum daily dose of 20 mg for a short-term, without medical advice, to a maximum of 4 weeks and daily intake Treatment of reflux symptoms limited to a maximum of 2 weeks (e.g. (e. g. heartburn and acid) in adults-
Papaverin
Paracetamol
-except for medicinal products for human use

a)

oral administration for symptomatic treatment of mild to moderately severe pain and/or fever in a total amount of active substance of up to 10 g per pack, and

b)

Rectal application-

Paliperidone
Parafluticide
Paraldehyde
Paramethadione
Paramethasone and its esters
Paraoxon
Human parathyroid hormone
Parbendazole
Parecoxib
Pargylin
Paricalcitol
Parnaparin
-for parenteral administration-
Paromomycin
Paroxetine
Pasireotide
Pazopanib
Pefloxacin
Peforelin
-for use in animals,
Pegaptanib
Pegaspargases
PEG-epoetin beta
Pegfilgrastim
Peginterferon alfa-2a
Peginterferon alfa-2b
Pegloticase
Pegvisomant
pemetrexed
Penbutolol
Penciclovir
-except for external use in herpes labialis in pack sizes of up to 2 g and with an active substance content of up to 20 mg per dose of medicinal product.
Penfluridol
Penfluticide
Pengitoxin
Penicillamine
Penoctonium bromide
-except in solutions, ointments and powders for external use in a concentration of up to 0.1% by weight,
Pentaerithrityltetranitrate
Pentagastrin
Pentamethonium salts
Pentamidine
Pentetreotide
Pentolonium salts
Pentorex
Pentosan polysulphate
-for oral and parenteral administration,
Pentostatin
Pentoxifylline
Perampanel
perchloric acid
Pergolid
Perhexiline
Perindopril
Permethrin
-for the treatment of scabies in humans-
-for use in animals, except

a)

as ear clip

b)

for use in horses,

Peruvosid
Phenacemid
Phenamacid
Phenelzine
Pheneticillin
Phenglutarimide
Phenindione
Pheniprazine
Phenothiazine
Phenothiazine, nitrogen substituted
Phenoxybenzamine
Phenoxymethylpenicillin
Phenprobamate
Phenprocoumon
Phensuximide
Phentolamine
Phenylbutazone
Phenylephrine
-for use in the eye, except in liquid preparations up to 2.5%,
((phenyl) (piperidin-2-yl) methyl) acetate
Phenylpropanolamine
-for the treatment of food-related overweight,
-for use in animals,
Phospholipids
-for parenteral administration without the addition of other active ingredients,
Phospholipids from cattle lung
-for the prophylaxis and therapy of the respiratory distress syndrome in premature infants-
Phospholipids from pig's lung
Phosphorus
Phoxim
-for use in animals,
Physostigmine
Picrotoxin
Pilocarpin
Pimecrolimus
Pimobendan
-for use in animals,
Pimozid
Pinaverium bromide
Pindolol
Pioglitazone
Pipamperon
Pipecuronium bromide
Pipemidic acid
Pipenzolatbromide
Piperacillin
Piperaquin
Piperazine, also known as Hydra
-as a worm-
Piperidolat
Piperoxan
Piperylon
Pipofezin
Pipoxolan
Piracetam
Pirbuterol
Pirenzepin
Piretanide
Pirfenidon
Piribedil
Piridoxilate
Pirlimycin
-for use in animals,
Piromitic acid
Piroxicam
-except for external use,
Pirprofen
Pitavastatin and its esters
Pivampicillin
Pivmecillinam
Pixantron
Pizotifen
Plerixafor
Plicamycin
Podophyllum-emodi radix et rhizoma and their preparations
Podophyllum peltatum, radix et rhizoma and their preparations
-except in homeopathic preparations for oral use produced in accordance with the rules 25 and 26 of the homeopathic medicinal book,
Podophylline
Podophyllinic acid and its derivatives
Podophyllotoxin
Podophyllum-emodi-and Podophyllum-peltatum-Glycosides and their derivatives
Polyestradiol
Polymyxin B and M
Poly (O-2-hydroxyethyl) starch
-for parenteral administration-
Poly (styrolco-divinylbenzene) sulphonic acid (x:y)
as aluminium, calcium, potassium and sodium salt
-except for use as an excipient for galenic purposes in a daily dose up to 300 mg-
Polythiazide
Pomalidomide
Ponatinib
Porfimer
Posaconazole
Practolol
Pradofloxacin
-for use in animals,
Prajmalium
Pramipexole
Pramiverin
Pranoprofen
Prasterone and its esters
Prasugrel
Pravastatin
Praziquantel

-

except for use

a)

in dogs and cats and

b)

in the case of ornamental fish of the orders, carp-like, bearded, puppies and toothpains with an active substance content of up to 20 g per pack,

Prazosin
Prednicarbat
Prednimustin
Prednisolone and its esters
Prednisone and its esters
Prednylidene and its esters
Pregabalin
Prenoxdiazine
Prenylamine
Pridinol
Prifinium hydroxide
-for use in animals,
Prilocain
-with the exception of medicinal products for application to the skin or mucosa, except for use in the eye,
Primaquin
Primidon
Primycin
Pristinamycin
Probucol
Procain
-with the exception of medicinal products for parenteral use without the addition of other active substances in concentrations up to 2% for intracutaneous use in healthy skin in the context of neural therapy,
-with the exception of medicinal products for application to the skin or mucosa, except for use in the eye,
Procainamide
Procarbazine
Procaterol
Procyclidine
Progesterone
Proglumetacin
Proglumid
Proguanil
Proligestone
Prolintan
promegestone
Promestries
Propafenone
Propamidine
Propanidid
Propanetetraphosphonic acid
-as a carrier substance for ((high) 99m Tc) technetium
Propanthelin bromide
Propicillin
Propiverine
Propofol
Propoxyphen
Propranolol
Propyl (3beta-(benzoyloxy) tropane-2alpha-carboxylate)
-for use in the eye,
Propylhexedrine
Proquazon
Prostals
-for use in animals,
protamine
(alpha (deep) 1) protein asa inhibitor of human
Prothipendyl
Protionamide
Protirelin
Logylol
-except for internal use, to the extent that the individual dose does not exceed 1 mg,
Protriptylin
Proxy metacaine
Prucaloprid
pseudoephedrine
-with the exception of medicinal products for use in humans with a total amount of active substance up to 720 mg of pseudoephedrine per pack-
Pteropterin
Pulsatillae herba and its preparations
-except in homeopathic preparations for oral use produced in accordance with the rules 25 and 26 of the homeopathic medicinal book,
Pyrantel
Pyrazinamide
Pyridostigmine bromide
Pyrimethamine
Pyriprol
-for use in animals,
Pyrithione-zinc
-except for external use

a)

in a concentration of up to 0.2%

b)

in a concentration of up to 1% in preparations which are rinsed off again,

Pyrithyldionmercury and its compounds
-except

1.

2-(ethylmercurithio) benzoic acid, sodium salt (thiomersal)

a)

in tablets up to 30 mg for the control of the Nosema-Seuche,

b)

up to 0.004 percent by weight in storage and wetting solutions for contact lenses,

2.

2-(ethylmercurithio) benzoic acid and its salts, phenylmercuriacetate, phenylmercuriborate, phenylmercurinitrate preservative in a concentration of up to 0.002% by weight in liquid preparations, emulsions and ointments,

3.

Quininmercuribisulfate in a concentration of up to 2.75% by weight in preparations in small packs for use in men for the prevention of sexually transmitted diseases,

4.

Phenylmercuriborate in a concentration of up to 0.1% by weight for external use in preparations of up to 50 ml, respectively. 50 g-

Quetiapin
Quinagolide
Quinapril
Quinaprilat
Quinestrol
Quinethazon
Quingestanol
Quinisocain
-with the exception of medicinal products for application to the skin or mucosa, except for use in the eye,
Quintiofos
Quinupristin
Rabeprazole
Racecadotril
-except in solid preparations for the symptomatic treatment of acute diarrals in adults over 18 years of age in concentrations of 100 mg per divided form and in a total quantity of up to 1 000 mg per pack for maximum Application period of three days, provided that the subject information and the package leaflet are

a)

The contraindications indicate that raclecadotril should not be used in cases of fever, bloody or slime stools, as these are due to the presence of invasive bacteria or other serious diseases. or during or after taking antibiotics (pseudomembranous colitis), and

b)

the warnings indicate that Racecadotril should be administered only in accordance with a medical prescription if the diarth is an acute thrust of ulcerative colitis or if the patient is under a kidney or a kidney or a kidney or a kidney or a kidney or a non-colitis. hepatic insufficiency-

Racefemin
Radionuclide-containing substances and preparations for diagnostic or therapeutic purposes
Raloxifen
Raltegravir
Ramifenazon
-for parenteral administration-
-except for use in animals,
Ramipril
Ranelic acid
Ranitidine
-except in preparations for oral use, at a concentration of up to 75 mg per divided form and in pack sizes of up to 1 050 mg, provided that the application for adults and children is completed at 16. Year of life in the fields of application "In case of heartburn and/or acid discharge" and limited to a maximum treatment duration of 14 days,
Ranolazine
Rasagiline
Rasburicase
Predatory species, their preparations and alkaloids, except in homeopathic preparations for oral administration, which are manufactured in accordance with the rules 25 and 26 of the homeopathic medicinal book,
Reboxetine
Regadenoson
Regorafenib
Repaglinide
Reproterol
Reserpin
Resocortol and its esters
-for use in animals,
Resorantel
Retapamulin
Reteplase
Retigabin
Retinol and its esters
-for use in human beings,
-except for internal use in preparations with a daily dose of up to 10 000 IU.-
-except for external use in preparations with a daily dose of up to 50 000 IU.
Reviparin
-for parenteral administration-
Ribavirin
Ribostamycin
Rifabutin
Rifampicin
Rifamycin
Rifaximin
Rilonacept
Rilpivirin
Riluzole
Rimazolium metilsulphate
Rimexolon
Rimonabant
Risedronic acid
Risperidone
Ritodrin
Ritonavir
Rivaroxaban
Rivastigmine
Rizatriptan
Robenacoxib
-for use in animals,
Rocuronium bromide
Roflumilast
Rolitetracycline
Romifidin
in horses, dogs and cats-
Romiplostim
Ronidazole
-for use in animals,
Ropinirol
Ropivacain
Rosiglitazone
Rosoxacin
Rosuvastatin
Rotigotine
Roxatidin and its esters
Roxithromycin
Rupatadin
Ruxolitinib
Sabinae oleum
Sabinae summitates-and their preparations
except for external use in ointments,
Rufinamide
Salbutamol
Salmeterol
Nitric acid
-in preparations containing acetic acid and oxalic acid,
Salverin
Samarium ( ^153Sm ) lexidronam
Santonin
Sapropterin (including its stereoisomeric mixtures)
Saquinavir
Sarafloxacin
-for use in animals,
Saralasin
Saxagliptin and its esters
Scammoniae resina and its preparations
Thyroid active substances
Sulphur hexafluoride
Scilla-glycosides
Scopolamine
Scopoliawurzelstock and its preparations
Secale-alkaloids
Secale cornutum and its preparations
Secnidazole
Secretin
-for use as a diagnostic agent,
Selamectin
Selegiline
Selenties
-with the exception of selenium sulphide for external use, in a concentration of up to 2.5% by weight,
-except in preparations for internal use, with a daily dose of up to 50 my g selenium-
Sera and monoclonal antibodies
-for use on or in the human or animal body,
Sermorelin
serrapeptase
Sertindol
Sertraline
Sevelamer
Sevofluran
Sibutramin
Silver nitrate
-except for external use and in eye drops for glorrhoeprophylaxis-
Silver Connections
-for use in disorders of the gastrointestinal tract-
Sildenafil
Silibinin-C-2 ', 3-bis (hydrogen succinate)
-for parenteral administration-
Silodosin
Simvastatin
Sincalid
Sipuleucel-T
Sirolimus
Sisomicin
Sitagliptin
Sitaxentan
Solifenacin
Somatorelin
Somatostatin
Somatropin
Sorafenib
Sotalol
Spagluminic acid
-for the treatment of seasonal rhinitis,
Sparfloxacin
Partner
-except for external use,
Spectinomycin
Spinosad
-for use in animals,
Spiramycin and its esters
Spirapril
Spironolactone and its esters
Stanozolol and its esters
Stavudine
Coal tar and its preparations
Nitrogen monoxide
Stilbamidine
(E) -Stiripentol
Substances and preparations of substances intended for the elimination of amenorrhoea, even if they are announced as agents for disorders of general, period or menstrual disorders, for use in humans
Bark and its preparations
-containing at least 50% total procyanidine, calculated as cyanidine chloride,
Streptokinase
-except for buccal or oral use-
Streptomycin
Strophanthi semen and its preparations
Strophanthine
Strychni semen and its preparations
-except in homeopathic preparations for oral use produced in accordance with the rules 25 and 26 of the homeopathic medicinal book,
Strychnin
Strychnin-N-oxide
Strychnic acid
Sucralfat
Sugammadex
Sulbactam
Sulfacarbamide and its derivatives
Sulfaguanidin and its derivatives
Sulfanilamide and its derivatives
Sulfasalazine
Sulfinpyrazon
Sulphone
Sulindac
Suloctidil
Sulodexide
-for parenteral administration-
Sulpiride
Sulproston
Sultamicillin
Sultiam
Sumatriptan
Sunitinib
Suramin sodium
Suxamethonium salts
Suxibuzon
SyrosingopinTacalcitol
Tacrin
Tacrolimus
Tadalafil
Tafamidis and its esters
Tafluprost
Talastin
Talinolol
Tamoxifen
Tamsulosin
Tasonermin
Taurolidin
Tazarotene
Tazobactam
Teduglutide
Tegafur
Teicoplanin
Telaprevir
Telavancin
Telbivudine
Telithromycin
Telmisartan
Temocapril
Temoporfin
Temozolomide
Temsirolimus
Tenecteplase
Teniposid
Tenofovir and its esters
Tenonitrozole
Tenoxicam
Tepoxalin
-for use in animals,
Terazosin
Terbinafin
-except for external use,
Terbutaline
Terfenadine
Teriflunomide
Teriparatide
Terizidon
Tertatolol
Testolactone
Testosterone and its esters
Tetrabenazine
-for the treatment of dyskinetic movement disorders-
Tetracaine
Tetrachloroethylene
-except for external use,
Carbon tetrachloride
Tetracycline and its compounds
4-epi-tetracycline
Tetraisopropyl pyrophosphate
Tetr akis (2-methoxy-2-methylpropylisocyanid) copper (1 +)-tetrafluoroborate
-as a carrier substance for ((high) 99m Tc) technetium
Tetramisol
Tetrofosmin
Tetroxoprim
Tetrylammonium salts
Thalidomide
Thallium
Thenalidin
Theodrenaline
-for parenteral administration-
Theophylline
Theophyllin-ethylenediamine
Theophyllin-magnesium acetate
Theophylline-(2-amino-2-methylpropan-1-ol) (1: 1)
Therapeutic allergens
Thevetin
Thiamazol
Thiambutosin
Thiamphenicol and its esters
Thibenzazoline
Thiobarbituric acid derivatives
Thiostrepton
Thiotepa
Thiouracil and its derivatives
Thyroideae glandulae siccatae and their preparations
Thyrotropin alfa
Tiabendazole
Tiagabin
Tiamulin
-for use in animals,
Tianeptin and its esters
Tiapride
Tiaproic acid
Tiaprost
-for use in animals,
Tibolon
Ticagrelor and its esters
Ticarcillin
Ticlopidin
Tigecycline
Tildipirosin
-for use in animals,
Tiletamine
-for use in animals,
Tilmicosin
Tiludronic acid
Timolol
Tinidazole
Tinzaparin
-for parenteral administration-
Tiocarlid
Tioconazole
-except for external use,
Tioguanine
Tiomesteron
Tiopronin
Tiotix
Tiotropium bromide and its hydrat
Tipranavir
Tiracizine
Tirofiban
Tiropramide
Tixocortol and its esters
Tizanidin
Tobramycin
Tocainid
Toceranib
-for use in animals,
Tocofersolan and its esters
-in the case of vitamin E deficiency due to digestive malabsorption in paediatric patients-
Tolazamid
Tolbutamide
Tolcapone
Tolciclat
Tolfenamic acid
-for use in animals,
Toliprolol
Tolmetin
Tolonium chloride (toluidine blue)
-for parenteral administration-
Tolperison
Tolterodin
Toltrazuril
Tolvaptan
Topiramate
Topotecan
Torasemide
Toremifene
Trabectedin
Tramadol
Trandolapril
Tranexamic acid
Transcalcifediol
Tranylcypromine
Trapidil
Travoprost
Trazodone
Treosulfan
Treprostinil
Tretamine
Tretinoin
Triacetyldiphenolisatin
Triamcinolone as well as its esters and ethers (including the acetals)
Triamcinolonacetonide and its esters
-except for use as adhesive tablets for recurrent Aphthene
Triamteren
Triaziquon
Tribenoside
2,2,2-Tribromethanol
Trichlormethiazid
Trichloromethine
Trichloroethylene
-except for external use,
Triclabendazole
Trifluperidol
Trifluridine
Trihexyphenidyl
Trilostan
trimegestone
Trimetaphane salts
Trimetazidine
Trimethadione
Trimethidinium methosulphate
Trimethoprim
trimethylolmelamine
(2-Oxo-2-(2,4,5-trimethylanilino) ethyl) azandiyl) diacetic acid
-as a carrier substance for ((high) 99m Tc) technetium
Trimetozine
Trimipramin
Triparanol
Triperiden
Triptorelin
Trofosfamide
Troleandomycin
Trolnitrate
Tromantadin
Trometamol
-for parenteral administration in the event of disturbances of the acid-base budget or for the urinary alkalization in the case of intoxications or with a content of more than 1 g of trometamol of the pharmaceutical form divided into each case-
Tropalpin
-with the exception of preparations for internal use, in so far as the content of the single dose does not exceed 1 mg,
Tropenziline
Tropicamide
Tropinobenzilate
Tropisetron
-for use in chemotherapy-induced and post-operative vomits-
Trospium salts
Trovafloxacin
Tryptophan
-for the treatment of depressive disorders-
Tuberculins, liquid or dry preparations, and any other preparations obtained from or using tubercle bacilli
Tubocurarin
Tulathromycin
-for use in animals,
Tulobuterol
Tylosin
Tylvalosin (acetylisovaleryltylosin) and its esters

Ulipristal and its esters
-with the exception of the ellaOne ® ready-to-use medicinal product for emergency contraception authorised in accordance with Article 3 (1) of Regulation (EC) No 726/2004,
Unoproston-isopropyl
Urapidil
Urethane
Urofollitropin
Urokinase
Ursodeoxycholic acid valaciclovir
Valdecoxib
Valdetamid
Valganciclovir
Valnemulin
Valproic acid
Valsartan
Vancomycin
Vandetanib
Vardenafil
Vareniclin
Vasopressin and its analogues
Vecuronium bromide
Vedaprofen
-for use in animals,
Velaglucerase alfa
Vemurafenib
Venlafaxine
Verapamil
Veratri rhizoma and its preparations
-except for external use in animals and as Schneeberger snuff with a content of no more than 3% by weight of niesium root-
Veratrum alkaloids
Vernakalant
Verteporfin
Vidarabin
Vigabatrin
Vilanterol
Vildagliptin
Viloxazine
Vinblastin
Vincamine
Vincristin
Vindesin
Vinflunin
Vinorelbin
Vinpocetin
Viomycin
Viquidil
Virginiamycin
Vismodegib

Preparation from
Lidocaine
and
Prilocain
-for the treatment of primary premature ejaculation in adult males-

VoriconazolWarfarinXantocillin
Xenon
Ximelagatran
Xipamide
Xylazinyohimbinic acid and its esterzalcitabine
Zaleplon
Zanamivir
Cells of human or animal origin in fresh, frozen or dried condition, to the extent that they are intended for injection or infusion in humans
Zeranol
Ziconotide
Zidovudine
Zinc oxide for oral use in humans
-except in daily doses up to 25 mg zinc-
Zinc
-except

1.

on external use

2.

in eye drops

3.

for oral use

a)

in the case of human beings, provided that a daily dose corresponding to a zinc content of up to 25 mg is indicated on containers and outer envelopes;

b)

in animals,

Ziprasidon
Zofenopril
Zolazepam
-for use in animals,
Zoledronic acid
Zolmitriptan
Zonisamide
Zopiclon
Zorubicin
Zotepin

Preparation from
Amitraz,
Fipronil
and
Methoprene
-for use in dogs,

Preparation from
Colfosceril,
1-Hexadecanol
and
Tyloxapol

Preparation from
Emodepside
and
Praziquantel
-for use in animals,

Preparation from
Emodepside
and
Toltrazuril
-for use in animals,

Preparation from
Florfenicol
and
Flunixin
-for use in animals,

Preparation from
Flumethrin
and
Imidacloprid
-for use in cats,

Preparation from
Gimeracil,
Oteracil and its Esters
and
Tegafur

Preparation from
Imidacloprid
and
Permethrin
-for use in dogs,

Preparation from
Indoxacarb
and
Permethrin
-for use in animals,

Preparation from
Ivermectin
and
Praziquantel
-for use in horses,

Preparation from
Lufenuron
and
Milbemycinoxim
-for use in dogs,

Preparation from
Marbofloxacin,
Clotrimazole
and
Dexamethasone acetate
-for use in dogs,

Preparation from
Metaflumizon
and
Amitraz

Preparation from
Methoprene
and
Fipronil
-for use in dogs and cats,

Preparation from
Milbemycinoxim,
Lufenuron
and
Praziquantel
-for use in animals,

Preparation from
Milbemycinoxim
and
Praziquantel
-for use in dogs and cats,

Preparation from
Nicotinic acid
and
Laropiprant

Preparation from
Oxantel,
Praziquantel
and
Pyrantel
-for use in animals,

Preparation from
Permethrin
and
Pyriproxifen
-for use in dogs,

Preparation from
Xylometazoline
and
Ipratropium bromide and its Esters

Preparations of substances in pastes-, ointments-, gel-like or similar properties as well as emulsions and solutions for introduction into the uterus and in the context of veterinary medicine in addition in the vagina and udder of the animals

Zuclopenthixol and its esters Unofficial table of contents

Appendix 2 (to § 6)
Substances according to § 6

The plant contains an alphabetically ordered list of substances, with the basic use of the INN nomenclature.

1.

EnilconazolFlunixinMeclofenamic acid

2.

The following substances, in so far as they are contained in medicinal products, which are also or exclusively intended for infusion or injection, except for subcutaneous injection. (2-aminoethyl) dihydrogen phosphate arginine beta-carotenboric acid bromohexinbutafosfancalcium casein hydrolyscocarboxylaseColecalciferolcyanocobalamin dexpanthenoldimethiconethanol fructoseGlucoseHistidin4,5-O-hydroxyboranediyl-D-gluconic acid isoleucine potassium leucine Lysine hydrochloride Magnesium MenadionMethionine Sodium riboflavin 5 '-hydrogenphosphate nicotinamide phenylalanine Procainpyridoxine retinolpalmitate sorbitol listed in Table 1 of the Annex to Commission Regulation (EU) No 37/2010 of 22 December 2001. 2009 on pharmacologically active substances and their classification as regards maximum residue limits in foodstuffs of animal origin (OJ L 327, 30.4.2004, p. 1) are listed in the current version and for which this Regulation only provides for use in homeopathic veterinary medicinal products, prepared in accordance with homeopathic pharmacopoeia , although the maximum concentration indicated is maintained, thiamine chloride hydrochloride threonine tocopherol acetate toldimfos sodium tryptophanvaline valinVetrabutin.